LabConnect, a global provider of central laboratory services and functional service provider solutions for clinical trials, today announced the launch of SampleGISTICS® 2.0, an application that ...

Large-scale flow cytometry delivers critical biological insight by enabling multidimensional analysis of individual cells, ...

Strategic data selection and curation practices significantly reduce annotation costs and drive development productivity.

New federal data shows a sample at Bush Field’s plant tested 10.9 times over the EPA’s new PFOS limit.

Despite advancements, cryo-EM sample preparation remains a bottleneck, affecting structural biology and protein science through intrinsic disorder challenges.

Founded in 2023 and regarded as one of Silicon Valley's hottest start-ups, Mercor, valued at $10 billion, works with AI ...

Florida might execute an innocent man. Prosecutors are preventing DNA analysis that would add certainty to the case.

Every second, scientific experiments produce a flood of data—so much that transmitting and analyzing it can slow down even ...

In today's ACT Brief, we examine why eClinical platforms must prioritize user workflows over data flow, how digitizing sample tracking prevents integrity failures in transit, and the FDA's ...

The development of SampleGISTICS 2.0 is based on insights from millions of samples gathered in global clinical trials.

Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...